Breakthroughs in Seizure Monitoring with AI: A Deep Dive with Enlighten AI's Founder

In this compelling episode of our DeltaHealth Tech Podcast, we explore groundbreaking advancements in seizure monitoring facilitated by AI, featuring an in-depth discussion with Himanshu Misra, the founder of Enlighten AI. Misra shares his deeply personal journey that led him to innovate in the field of epilepsy treatment after the tragic loss of his son to the condition. Enlighten AI develops software solutions that enhance the monitoring and management of seizures, allowing for real-time data analysis and improved treatment personalization.The episode delves into how the software, deemed a medical device by the FDA, functions by aggregating neurological data from various devices and translating it into actionable insights for physicians. Misra explains the significance of integrating patient and caregiver inputs to provide a comprehensive view of seizure activities, which can significantly influence treatment decisions. The technology not only tracks seizures but also aids neurologists in optimizing medication dosages based on precise data-driven insights.As we navigate through Misra's narrative and the technical aspects of Enlighten AI’s platform, the conversation also covers the emotional and operational challenges faced while steering a startup in the complex landscape of healthcare innovation. This episode is a must-watch for anyone interested in the intersection of AI, patient care, and personal passion driving technological advancements in healthcare.00:00 Introduction with Roupen Odabashian01:00 Introduction to Enlightened AI and its goals03:00 Overview of Enlightened AI's software platform05:00 Discussing the patient journey with the platform07:00 How patients interact with the platform09:00 Integration of medical devices with the platform11:00 Device data integration and transmission details13:00 Data types collected by the platform15:00 Provider perspective on platform usage18:00 Access and alert customization for providers25:00 Business model and patient affordability28:00 Detailed business model discussion30:00 Differentiating seizures without EEG technology32:00 Challenges and research in progress35:00 Founding journey and initial challenges37:00 Lessons learned from building the companyRoupen Odabashian: LinkedIn: https://www.linkedin.com/in/roupen-odabashian-183aaa142/ X: https://twitter.com/RoupenMD Email: [email protected]: @DeltaHealthinnovators Himanshu Misra: LinkedIn: https://www.linkedin.com/in/himanshumisraphd/Website: https://enlitenai.com/